July 10, 2010
Maximum tolerated exposure: A more rational approach to drug dosing (Read More)
November 4, 2009
Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes (Read More)
October 25, 2009
Saladax CEO Salvatore Salamone featured in College of American Pathologists CAP Today Front Page Article: Uneasy Alliance -- TDM, Oncology Drugs (Read More)
September 26, 2009
Saladax cited by U.S. Commerce Dept. Secretary Locke during Ben Franklin Technology Partners visit (Read More)
May 12, 2009
Personalized Medicine Coalition Publishes The Case for Personalized Medicine, an Updated Report and Analysis on Advances and Challenges (Read More)
April 27, 2009
Myriad Genetics Launches OnDose, Its Seventh Molecular Diagnostic Product
OnDose Assists Oncologists in Maximizing Chemotherapy Efficacy and Reducing Toxicity
(Read More)
October 7, 2008
Myriad Genetics (Nasdaq: MYGN, www.myriad.com) Acquires Novel Therapeutic Drug Management Technology from Saladax Biomedical
(Read More)